Stoke Therapeutics Inc. (STOK)
6.28
-0.32 (-4.85%)
At close: Apr 03, 2025, 1:15 PM
13F Institute Ownership
Total Institutes of 131 in Stoke Therapeutics expanded their positions with an increase of 11 investors compared to the previous quarter. A reduction of 156.06K shares, as total invested capital declined by $74.47M with ownership percentage dropping from 103.33% to 103.05%.
Options Activity
Institutions are holding more Puts Contracts as Calls Contracts, indicating a bearish sentiment.
Put/Call 7.933
7.93
Call Flow 3,000
11%
Put Flow 23,800
89%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Skorpios Trust | 12.26% | 6.91M | -22.46% | 76.18M | 99.80% |
| Blackrock, Inc. | 10.45% | 5.89M | +5.70% | 64.94M | < 0.01% |
| Lynx1 Capital Management LP | 9.21% | 5.19M | +0.00% | 57.21M | 21.45% |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.